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ABSTRACT
Background: Metabolic Syndrome (MetS) is a 
constellation of clinical features that increase 
cardiovascular morbidity and mortality in 
individuals. Up-to-date, there is no cheap, single 
surrogate test for MetS and current diagnostic 
criteria for the syndrome use scoring systems which 
are laborious, and the associated blood lipid tests are 
expensive and thus not adaptable to low resource 
countries such as Zambia.
Objective: The aim of the current study was to 
determine the predictive value of individual 
components of MetS in detecting the syndrome in 
patients with type 2 DM so as to explore simpler and 
cheaper alternative diagnostic approaches.
Materials and Methods:  This was a cross-sectional 
hospital based study of 400 medical outpatients with 
type 2 DM. The National Cholesterol Education 
Program Adult Treatment Panel III (ATP III) was 
used as the standard diagnostic test and components 
of MetS that were measured included waist 
circumference, blood pressure, fasting blood sugar, 
fasting serum triglycerides and HDL cholesterol. 
We defined abdominal obesity as waist 
circumference ≥ 94cm for men and ≥80cm for 
women. The sensitivity, specificity, predictive 
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values and likelihood ratios of individual 
components of MetS were determined.
Results:  The prevalence of MetS using ATP III was 
73% (91% in women and 50% in men; 
p<0.001).The presence of a large waist 
circumference had sensitivity and specificity of 
90% with likelihood ratio of 9 and positive and 
negative predictive values of 96% and 78% 
respectively in predicting type 2 DM patients with 
MetS. Hypertension had sensitivity of 94% and poor 
specificity of 56% and thus a low likelihood ratio of 
2. The positive and negative predictive values were 
8 5 %  a n d  7 8 %  r e s p e c t i v e l y .  B o t h  
hypertriglyceridemia and low serum HDL levels 
had poor sensitivities of 42% and 28% but had high 
likelihood ratios (11 and 14 respectively) due to high 
specificities (96% for hypertriglyceridemia, 98% 
for low HDL). The negative and positive predictive 
values for hypertriglyceridemia were 97% and 38% 
respectively whereas low HDL had 98% and 33% as 
positive and negative predictive values for MetS. 
The presence of a high BMI had sensitivity of 56%, 
specificity of 80%, likelihood ratio of 3 and positive 
and negative predictive values of 88% and 40% 
respectively.
Conclusions: In Zambian patients already suffering 
from type 2 DM, a large waist circumference is a 
fairly sensitive (90%) and specific (90%) test in 
predicting MetS with negative and positive 
predictive values of 96% and 78% respectively. And 
a type 2 DM patient with a large waist circumference 
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is 9 times more likely to have MetS than one with 
normal waist circumference, with a posttest 
probability of 96%. Therefore, simple waist 
circumference measurement can be used alone as an 
alternative cheaper surrogate test to detect MetS in 
patients with type 2 DM.
INTRODUCTION
Metabolic syndrome (MetS) is the clustering of 
three or more risk factors for cardiovascular disease 
in one individual. These risk factors include type 2 
diabetes mellitus (DM), high blood pressure, high 
serum triglycerides, low levels of High Density 
Lipoprotein cholesterol (HDL) and abdominal 
1,2,3,4,5obesity . Each individual component of the 
MetS carries a high risk for cardiovascular disease 
and a combination of three or more in one person has 
6an additive effect . Therefore, recognizing MetS in 
patients is important because it acts as a clinical tool 
for identifying individuals at high risk of 
cardiovascular morbidity and mortality so as to 
initiate lifestyle and medical interventions early 
.7
enough to avert complications
Since its first official definition by the World Health 
1,5,8,9
Organization (WHO) in 1999  the diagnostic 
criteria for MetS has undergone a lot of 
2modifications . Despite these efforts, diagnostic 
criteria for MetS use scoring systems such as the 
5 1,10harmonized  criteria and ATP III  which are 
laborious and the associated blood lipid tests are 
expensive and thus may delay diagnosis and 
treatment of the MetS. Type 2 DM patients are 
particularly at risk with about 75% to 80% estimated 
to have the MetS. There is growing evidence that 
simple waist circumference measurement may be 
11,12,113used alone to diagnose MetS.  Previous 
11,12,13studies  have assessed the predictive value of 
MetS components for insulin resistance compared 
to ATP III but there is a subsection of patients that do 
not have insulin resistance but have MetS and these 
studies were done in asymptomatic whites. 
Furthermore, the expressivity of MetS varies across 
8populations  and study findings elsewhere may not 
apply to Zambia. To the best of our knowledge 
previous studies have not assessed the predictive 
value of individual components of MetS among 
Zambian patients suffering from type 2 DM. 
The aim of the current study was to determine the 
predictive value of individual components of MetS 
in detecting the MetS in patients that already have 
type 2 DM so as to explore simpler and cheaper 
alternative diagnostic approaches.
RESEARCH  DESIGN  AND  METHODS
This cross sectional study recruited 400 medical 
outpatients at the University Teaching Hospital 
(UTH), Lusaka, Zambia. These were patients 
already confirmed to have type 2 DM by the 
attending physicians. Written consent was obtained 
from the University of Zambia Biomedical Research 
Ethics Committee (UNZAREC) and individual 
patients. Patients were identified using file review as 
they were waiting to be attended to. 
Demographic data and past medical and drug history 
focused on diabetes and hypertension were obtained 
from each patient. Thereafter, a physician examined 
the patient to determine   waist circumference, blood 
pressure, height, weight and to exclude confounders 
such as ascites, abdominal masses and pregnancy. 
Waist circumference was measured in centimeters 
using a tape measure at the level of the umbilicus 
without top garments in the supine position. Height 
was measured in meters without head dress or 
footwear and weight was measured in kilograms 
without footwear. Body mass index was calculated 
by dividing height squared into the weight. Blood 
pressure was measured using a mercury 
sphygmomanometer after a patient had rested for at 
least 10 minutes. For each patient two blood pressure 
readings were taken 5 minutes apart, one in the 
sitting position and the other in the supine position 
and the final reading was the average of the two 
readings. To exclude inter-observer bias all clinical 
examinations were done by the same physician. For 
each patient, blood sugar, serum triglycerides and 
HDL were measured. Epi Info version 3.3.2 was 
used for data entry and analysis.
Metabolic syndrome definition
Since all study participants had type 2 DM only two 
of the following ATP III criteria were needed to 
establish the diagnosis of MetS,
1. Abdominal obesity with waist circumference for 
men ≥ 94cm and for women ≥80 cm,
2. Blood pressure > 130 systolic and/or 
>85mmHg diastolic on at least two or more 
occasions or drug treatment for elevated blood 
pressure.
3. Fasting triglycerides ≥ 1.7mmol./L, or drug 
treatment for elevated triglycerides.
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4. Fasting HDL-cholesterol <0.9mmol/L in males 
and <1.0mmol/L in females or drug treatment for 
reduced HDL cholesterol.
Statistical analysis
Clinical and biochemical data was summarized by 
computing means ± standard deviation (SD) for 
continuous variables and percentages for 
categorical variables. Each patient was evaluated for 
the presence of MetS using the data obtained on 
blood pressure, waist circumference and fasting 
serum levels of triglycerides and HDL cholesterol. 
Unpaired student t-test was used to determine the 
differences in the distribution of continuous 
variables between males and females and the level 
of statistical significance was set at the 0.05 level. 
Using the ATP III as the standard test, we computed 
sensitivity, specificity, positive predictive values, 
negative predictive values, likelihood ratios and 
posttest probabilities for each attendant component 
of MetS so as to determine their predictive value in 
identifying type 2 DM patients with the syndrome. 
RESULTS
Out of the 400 patients recruited into the study 
222(56%) were women. The age range was 38- 96 
years with a mean of 59.30±11.13 (SD) years. On 
average women were older and had larger waist 
circumferences than men. There was no significant 
gender difference in terms of height, weight and 
BMI. And all hypertensive patients in the study were 
already on antihypertensive drugs probably 
contributing to the mean systolic BP of 133±24 
reported.
Table 1: Participants' clinical and biochemical characteristics
All data are means ± SD
Based on the ATP III criteria, prevalence of MetS 
was 73 % and was more common in women than in 
men (91% and 50% respectively, P< 0.001). All 
components of MetS were significantly more 
prevalent in women than men except for serum 
triglycerides. 
Table 2: Prevalence of MetS and its components among type 2 
DM patients.
All data are n (%)
*Waist circumference
A combination of type 2 DM + large waist 
circumference + hypertension was the most 
common (68%) diagnostic triad for MetS and the 
prevalence of this triad was significantly higher in 
women than in men just like a combination of type 2 
DM + low HDL + large waist circumference and 
type 2 DM + hypertension + low HDL. This is 
illustrated in table 3 below.
Table 3: Diagnostic triads of MetS among Zambians with type 2 
DM
All data are n (%)
*Waist circumference
Predictive value of MetS components in detecting 
the MetS in patients with type 2 DM
A large waist circumference had a sensitivity of 90% 
(90% in women, 92% in men) and specificity of 90% 
(86% in women, 91% in men) with positive and 
negative predictive values of 96% (98% in women, 
91% in men) and 78% (47% in women, 92% in men) 
respectively in detecting MetS in type 2 DM 
patients. The posttest probability for waist 










































82.90 ± 13.70 82.70 ± 12.34 83.10 ± 15.28 0.795
BMI (Kg/m2) 25.70 ± 5.21 25.90 ± 4.71 25.50 ± 5.78 0.450
Waist circumference (cm) 90.90 ± 14.84 93.10 ± 13.36 88.10 ± 16.12 <0.001
Fasting  blood sugar (mmol./l) 8.97 ± 3.80 9.06 ± 3.30 8.85 ± 4.36 0.586
Serum Triglycerides (mmol./L) 1.77 ± 1.61 1.81 ± 1.82 1.71 ± 1.30 0.583
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Type 2DM + 
Hypertriglyceridaemia + low 
HDL
44(11) 24(11) 20(11) 0.893
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men) and a type 2 DM patient with a large waist 
circumference is 9 times more likely to have the 
MetS than one with a normal waist circumference.
Table 4 Predictive value of MetS components in identifying the 
syndrome in patients with type 2 DM
*Waist circumference
Hypertension had a sensitivity of 94% (95% in 
women, 93% in men), specificity of 56% (33% in 
women, 62% in men) and thus the low likelihood 
ratio of 2 observed. The positive and negative 
predictive values were 71% (93% in women, 71% in 
men) and 91% (39% in women, 90% in men) 
respectively, with posttest probability of 85% (79% 
in women, 87% in men).
Hypertriglyceridemia was 42% sensitive (38% in 
women, 48% in men), 96% specific (100% in 
women, 96% in men) with positive predictive value 
of 97% (100% in women, 92% in men) and negative 
predictive value of 38% (15% in women, 65% in 
men). The likelihood ratio was 11 with a posttest 
probability of 97% (100% in women, 53% in men).
Low HDL levels were 28% sensitive (28% in 
women, 26% in men), 98% specific (100% in 
women, 98% in men) with positive and negative 
predictive values of 98% (100% in women, 92% in 
men) and 33% (13% in women, 57% in men) 
respectively in identifying study participants with 
the MetS. A Zambian type 2 DM patient is 14 times 
likely to have MetS than one with high fasting serum 
HDL levels. The posttest probability for low HDL 
was 97% (100% in women, 97% in men).
For BMI, the sensitivity was 56% (52% in women, 
62% in men) and specificity was 80% (57% in 
women, 84% in men) with likelihood ratio of 3. The 
positive and negative predictive values for MetS 
were 88% (92% in women, 80% in men) and 40% 
(11%in women, 69% in men) respectively, with a 























Pooled 90 90 96 78 9 96 
Male 92 91 91 92 10 97 
Female 90 86 98 47 6 94 
 
Hypertension 
Pooled 94 56 85 78 2 85 
Male 93 62 71 90 2 87 




Pooled 42 96 97 38 11 97 
Male 48 96 92 65 12 53 
Female 38 100 100 15 Infinite 100 
 
Low HDL 
Pooled 28 98 98 33 14 97 
Male 26 98 92 57 13 97 
Female 28 100 100 13 infinite 100 
 
High BMI 
Pooled 56 80 88 40 3 88 
Male 62 84 80 69 4 91 
Female 52 57 92 11 1 77 
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DISCUSSION
Diagnostic criteria for MetS use scoring systems 
which are laborious and the associated blood lipid 
tests are expensive and thus may delay diagnosis and 
treatment of the MetS. Type 2 DM patients are 
particularly at risk with about 75% to 80% estimated 
1to have the MetS.  The main objective of the current 
study was to determine the predictive value of MetS 
components in detecting the syndrome among 
patients already suffering from type 2 DM so as to 
find an alternative single surrogate test that is 
simpler and cheaper than counting MetS 
components.
In this study of black Zambians, the ATP III criteria 
were used as the standard test and our findings 
confirm that a large waist circumference is a fairly 
sensitive (90%) and specific (90%) test to identify 
type 2 DM patients with the MetS as defined by ATP 
III. Even though hypertriglyceridemia and low 
levels of HDL cholesterol have higher likelihood 
ratios (11 and 14 respectively) due to better 
specificity, they suffer poor sensitivity (42% for 
hypertriglyceridemia, 28% for low HDL) and 
n e g a t i v e  p r e d i c t i v e  v a l u e s  ( 3 8  f o r  
hypertriglyceridemia, 33% for low HDL) and above 
all they are more expensive to assess than waist 
circumference. Hypertension had higher sensitivity 
(94%) than a large waist circumference (90%) but it 
had poor specificity (56%) and thus a low likelihood 
ratio (2). A type 2 DM patient with a large waist 
circumference is nine times likely to have MetS 
compared to one with normal waist circumference, 
with a posttest probability of 96%. Most tests in 
medicine have likelihood ratios for a positive result 
1
between 1.5 and 20.  Higher values are associated 
with tests that are more accurate at identifying 
patients with disease, with values of 10 or greater of 
1particular note.  Even though women had larger 
waist circumferences than men and probably 
contributing to the higher prevalence of MetS 
observed in women, the specificity of a large waist 
circumference is lower in women (86%) compared 
to men (91%) and thus the lower likelihood ratio 
observed in women. And this may be due to the fact 
that the abdominal circumference in women may be 
increased during pregnancy and may remain as such 
even way after they have delivered and thus giving 
false positive results for abdominal obesity and 
subsequently MetS. For this reason, a diabetic man 
with a large waist circumference is more likely to 
have the MetS than a diabetic woman with a large 
waist circumference (likelihood ratio 10 in men, 6 in 
women). 
Previous studies
Even though the exact cause of the MetS is not 
known, both abdominal obesity and insulin 
1, 14, 15, 
resistance (IR) are believed to play a central role
16,17,18,19 13. A study in Cameroon  has even suggested 
that the prevalence of MetS in sub Sahara Africa may 
be driven by abdominal obesity which is diagnosed 
by simple waist circumference measurement. 
11,12,13Previous studies have compared the diagnostic 
accuracy of MetS components with ATP III criteria 
11
in detecting IR. For example a study by Justo et al  
among asymptomatic white patients in Minnesota, 
USA, reported that measuring waist circumference 
alone provided greater diagnostic accuracy than 
counting metabolic syndrome components as 
15
advocated for by ATP III. Two other similar 
12,13studies  before had reported similar findings that 
measures of obesity and dyslipidaemia have good 
predictive value for IR. But there is a subsection of 
patients without IR that have MetS. Furthermore, 
these earlier studies had used BMI as a measure of 
obesity instead of waist circumference and they were 
done among asymptomatic whites. To the best of our 
knowledge, the predictive value of MetS 
components in detecting the MetS in type 2 DM 
patients, as defined by ATP III, was not assessed in 
previous studies.
Study limitations
Even though we met the main objective of the study, 
the results may only apply to black Zambians with 
type 2 DM. Therefore, there is need to conduct a 
similar study in non diabetics and non black 
Zambians.
In summary, a large waist circumference is a fairly 
sensitive (90%) and specific (90%) test in predicting 
MetS with negative and positive predictive values of 
96% and 78% respectively. And a type 2 DM patient 
with a large waist circumference is 9 times more 
likely to have MetS than one with normal waist 
circumference, with a posttest probability of 96%. 
Therefore ,  s imple  wais t  c i rcumference  
measurement can be used alone as an alternative 
cheaper surrogate test to detect MetS in patients with 
type 2 DM.
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